TY - JOUR
T1 - A Dose-response relationship between severity of disc degeneration and intervertebral disc height in the lumbosacral spine
AU - Teichtahl, Andrew
AU - Urquhart, Donna Michelle
AU - Wang, YuanYuan
AU - Wluka, Anita Estelle
AU - Heritier, Stephane Roland
AU - Cicuttini, Flavia Maria
PY - 2015
Y1 - 2015
N2 - Introduction: Varied definitions of disc pathology exist in the literature. Magnetic Resonance Imaging (MRI) classification systems incorporate several qualitative features including disc appearance, the distinction between the nucleus and the annulus, signal intensity and intervertebral disc height. The lack of a continuous measure has made it difficult to sensitively examine degenerative disc disease. This study sought to examine the relationship between disc degeneration and intervertebral disc height. Methods: 72 community-based individuals not selected for low back pain had MRI from which the presence of lumbosacral disc degeneration was identified using the Pfirrmann grading system, and intervertebral disc height was measured. Results: At each lumbosacral level, with higher grade of disc degeneration, intervertebral disc height was reduced (all p=0.003). Results remained unchanged when grade 5 disc degeneration, which necessitated a collapsed disc space, was excluded from analyses (all p=0.03). To quantify these associations, at each lumbosacral level, for every grade increase in disc degeneration, there was a reduction in intervertebral disc height, after adjusting for age, gender, Body mass index and smoking history (? range from -0.98mm to -1.60mm, 95 CI range from -2.37 to -0.31, all p=0.005). Conclusion: This study has demonstrated a negative dose-response relationship between increasing severity of disc degeneration with a reduction in intervertebral disc height. Although the assessment of disc degeneration incorporates a number of qualitative measures, these data substantiate the utility of intervertebral disc height as a quantitative and continuous outcome measure in epidemiological studies, and potentially clinical practice.
AB - Introduction: Varied definitions of disc pathology exist in the literature. Magnetic Resonance Imaging (MRI) classification systems incorporate several qualitative features including disc appearance, the distinction between the nucleus and the annulus, signal intensity and intervertebral disc height. The lack of a continuous measure has made it difficult to sensitively examine degenerative disc disease. This study sought to examine the relationship between disc degeneration and intervertebral disc height. Methods: 72 community-based individuals not selected for low back pain had MRI from which the presence of lumbosacral disc degeneration was identified using the Pfirrmann grading system, and intervertebral disc height was measured. Results: At each lumbosacral level, with higher grade of disc degeneration, intervertebral disc height was reduced (all p=0.003). Results remained unchanged when grade 5 disc degeneration, which necessitated a collapsed disc space, was excluded from analyses (all p=0.03). To quantify these associations, at each lumbosacral level, for every grade increase in disc degeneration, there was a reduction in intervertebral disc height, after adjusting for age, gender, Body mass index and smoking history (? range from -0.98mm to -1.60mm, 95 CI range from -2.37 to -0.31, all p=0.005). Conclusion: This study has demonstrated a negative dose-response relationship between increasing severity of disc degeneration with a reduction in intervertebral disc height. Although the assessment of disc degeneration incorporates a number of qualitative measures, these data substantiate the utility of intervertebral disc height as a quantitative and continuous outcome measure in epidemiological studies, and potentially clinical practice.
UR - http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619538/pdf/13075_2015_Article_820.pdf
U2 - 10.1186/s13075-015-0820-1
DO - 10.1186/s13075-015-0820-1
M3 - Article
SN - 1478-6354
VL - 17
SP - 1
EP - 6
JO - Arthritis Research & Therapy
JF - Arthritis Research & Therapy
IS - 1 (Art. No: 297)
ER -